Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 3.0B | 2.8B | 2.9B | 2.8B |
Cost of revenue | 407.5M | 363M | 423.4M | 392.6M |
Gross profit | 2.6B | 2.4B | 2.5B | 2.4B |
Operating expense | ||||
Research & development | 978.4M | 979.7M | 5.6B | 875.9M |
Selling general and admin | 424.6M | 396.4M | 377.6M | 371.8M |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 1.0B | -3.5B | 1.1B |
Non operating interest income | ||||
Income | 122.4M | 120.9M | 128.2M | 132.2M |
Expense | 3.7M | 3M | 2.8M | 7.5M |
Other income expense | 10.1M | -418.6M | 4.5B | -32.2M |
Pretax income | 1.3B | 730.4M | 1.1B | 1.2B |
Tax provision | 250.1M | 84.1M | 223.5M | 178.7M |
Net income | 1.0B | 646.3M | 913M | 1.0B |
Basic EPS | 4.0 | 2.5 | 3.6 | 4.1 |
Diluted EPS | 4.0 | 2.5 | 3.5 | 4.0 |
Basic average shares | 256.7M | 256.9M | 257.5M | 258M |
Diluted average shares | 258.9M | 259.5M | 260.5M | 261M |
EBITDA | 1.3B | 1.2B | -3.4B | 1.3B |
Net income from continuing op. | 1.0B | 646.3M | 913M | 1.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |